Cancer survivorship--genetic susceptibility and second primary cancers: research strategies and recommendations.

doi:10.1093/jnci/djj001

Loading publication...

Noodle always counts identifier-free feature events for service operation. With your permission, Google Analytics can also estimate audience and engagement. Search text, publication identifiers, cookies, IP addresses and browser fingerprints are never included in Noodle's first-party event counters.

Privacy details

Community

Back to search

Article

Cancer survivorship--genetic susceptibility and second primary cancers: research strategies and recommendations.

Journal of the National Cancer Institute - 4 Jan 2006

Travis Lois B, Rabkin Charles S, Brown Linda Morris, Allan James M, Alter Blanche P, Ambrosone Christine B, Begg Colin B, Caporaso Neil, Chanock Stephen, DeMichele Angela, Figg William Douglas, Gospodarowicz Mary K, Hall Eric J, Hisada Michie, Inskip Peter, Kleinerman Ruth, Little John B, Malkin David, Ng Andrea K, Offit Kenneth, Pui Ching-Hon, Robison Leslie L, Rothman Nathaniel, Shields Peter G, Strong Louise, Taniguchi Toshiyasu, Tucker Margaret A, Greene Mark H

Abstract excerpt

Cancer survivors constitute 3.5% of the United States population, but second primary malignancies among this high-risk group now account for 16% of all cancer incidence. Although few data currently exist regarding the molecular mechanisms for second primary cancers and other late outcomes after cancer treatment, the careful measurement and documentation of potentially carcinogenic treatments (chemotherapy and...

Read the complete abstract on PubMed

Topics

Share this publication in a Topic to start or enrich a Post.

Share to Biotechnology

Methodology Data sources Editorial policy Privacy Delete account & data About Contact Helena Bioinformatics

Share to Congresses as Topic

Share to Medical Informatics

Share to Multicenter Studies as Topic

Share to Neoplasms, Radiation-Induced

Share to Radiotherapy

Share to Specimen Handling

Share to Survivors

Source

Open in PubMed

Identifiers

PMID: 16391368
DOI: 10.1093/jnci/djj001

Provenance

PubMed metadata and Literature Corpus relationships. Corpus snapshot updated 7 Sept 2026. Manifest publication-graph-cohort-2026-09-08.1.

Source receipt: pubmed, retrieved 7 Sept 2026.

Related research

Semantic proximity does not establish scientific evidence. Graph snapshot: 2026-09-29.

Research trail→

Click a neighbor to travelStep 1 · 12 closest

Cancer survivorship--genetic susceptibility and second primary cancers: research strategies and recommendations.PMID 16391368Read ↗

The epidemiology of second primary cancers.Semantic proximity Read ↗

Aetiology, genetics and prevention of secondary neoplasms in adult cancer survivors.Semantic proximity Read ↗

Solid tumor second primary neoplasms: who is at risk, what can we do?Semantic proximity Read ↗

Genetic variation as a modifier of association between therapeutic exposure and subsequent malignant neoplasms in cancer survivors.Semantic proximity Read ↗

Radiotherapy-Induced Malignancies: Review of Clinical Features, Pathobiology, and Evolving Approaches for Mitigating RiskSemantic proximity Read ↗

Second malignant neoplasms and cardiovascular disease following radiotherapy.Semantic proximity Read ↗

Identifying and screening patients at risk of second cancers.Semantic proximity Read ↗

Harvard report on cancer prevention. Causes of human cancer. Genetic susceptibility.Semantic proximity Read ↗

Integrated Clinicogenomic Risk Modeling for Metachronous Second Primary CancersSemantic proximity Read ↗

Tertiary prevention: implications for improving the quality of life of long-term survivors of cancer.Semantic proximity Read ↗

Chemoprevention of second cancers.Semantic proximity Read ↗

Emerging molecular technologies for identifying the risk of second cancers.Semantic proximity Read ↗

⌁Select a neighboring publication to make it the new centre.